NDC 0002-8980 – Rezvoglar KwikPen

Insulin Glargine 100 [iU]/mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC0002-8980

Product details

Brand name
Rezvoglar KwikPen
Generic name
Insulin glargine-aglr
Labeler
Eli Lilly and Company
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
BLA · BLA761215
Marketed since
December 17, 2021
Listing expires
December 31, 2026
Pharmacologic class
Insulin Analog

Active ingredients

Uses, dosage, side effects and warnings for Rezvoglar →

Package NDC codes (1)

Package NDCDescriptionSince
0002-8980-055 SYRINGE in 1 CARTON (0002-8980-05) / 3 mL in 1 SYRINGE (0002-8980-01)Dec 17, 2021